NumFin

Thyrocare Technologies Limited

Sümbol: THYROCARE.BO

BSE

603.8

INR

Turuhind täna

  • 50.3318

    P/E suhe

  • 0.9063

    PEG suhe

  • 31.97B

    MRK Cap

  • 0.00%

    DIV tootlus

Thyrocare Technologies Limited (THYROCARE-BO) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete Thyrocare Technologies Limited (THYROCARE.BO) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes Thyrocare Technologies Limited fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014

balance-sheet.row.cash-and-short-term-investments

01400.71388.41176.9
800.9
842.4
1119.6
1160.9
1107.1
893.8

balance-sheet.row.short-term-investments

012231252.11044.9
713.9
793.3
1021.4
1062
1003.6
843

balance-sheet.row.net-receivables

0856.7944.8513.5
170
124.6
99.1
64.2
140.8
124.5

balance-sheet.row.inventory

0276.7245.3233.6
206.2
180.8
170.5
145
107.2
73.7

balance-sheet.row.other-current-assets

053.2112.828.4
0.1
196.5
16.3
0
65.6
14.8

balance-sheet.row.total-current-assets

02729.42700.22404.4
1519.9
1360.2
1424
1495.3
1366.6
1106.7

balance-sheet.row.property-plant-equipment-net

01944.31867.91600.9
1725.8
1872.5
1901.8
1686.2
1523.8
1546.3

balance-sheet.row.goodwill

01002.81002.81002.8
1002.8
1068.6
1068.6
1068.6
1068.6
0

balance-sheet.row.intangible-assets

07.98.39.7
11.6
16.6
17.1
6.4
12.6
0

balance-sheet.row.goodwill-and-intangible-assets

01010.71011.11012.5
1014.4
1085.2
1085.7
1075
1081.2
469.3

balance-sheet.row.long-term-investments

0223.1243.8270.7
282.5
248.5
215.4
6.3
50.2
-826.9

balance-sheet.row.tax-assets

0122.764.956.3
20.3
51.4
52.3
37.9
23.4
8.7

balance-sheet.row.other-non-current-assets

0297188.7113.2
143.3
129.4
110.8
77.6
65.9
1976

balance-sheet.row.total-non-current-assets

03597.83376.43053.6
3186.3
3387
3366
2882.9
2744.4
2185.5

balance-sheet.row.other-assets

0000
0.1
0
0
0
0
0

balance-sheet.row.total-assets

06327.26076.65458
4706.3
4747.2
4790
4378.3
4111.1
3292.2

balance-sheet.row.account-payables

0239.9165.3250.1
218.6
75.1
65.9
13
18.4
8.3

balance-sheet.row.short-term-debt

071.95030.4
42.5
10.4
5.5
117.4
7.1
0

balance-sheet.row.tax-payables

018.318.318.6
9.7
10
10.1
12
17.4
0

balance-sheet.row.long-term-debt-total

0161.215754.5
81.9
25
-70.6
72.5
55
0

Deferred Revenue Non Current

00091.9
81.6
-69.5
0.1
0.2
3.4
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0398.4336.5312.5
249.1
74.8
99.5
136.8
104.8
64.7

balance-sheet.row.total-non-current-liabilities

0204165.7234.2
222.9
190.1
154.1
124
123.2
95.3

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0233.120784.9
99.4
0
0
0
0
0

balance-sheet.row.total-liab

0975810.91185.2
1039.8
396
357.1
300.2
275.3
168.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0

balance-sheet.row.common-stock

0529.3529528.7
528.4
527.9
537.2
536.9
536.9
505.4

balance-sheet.row.retained-earnings

03434.23568.82599.2
2010.1
2715.2
2186.5
1890.8
1947.2
1867.9

balance-sheet.row.accumulated-other-comprehensive-income-loss

01255.91244.11225.8
1200.8
1178.7
1809.5
1769.8
1770.2
0

balance-sheet.row.other-total-stockholders-equity

0123.6-76.2-80.9
-72.8
-70.6
-100.3
-119.5
-418.6
390.5

balance-sheet.row.total-stockholders-equity

053435265.74272.8
3666.5
4351.2
4432.9
4078.1
3835.7
2763.7

balance-sheet.row.total-liabilities-and-stockholders-equity

06327.26076.65458
4706.3
4747.2
4790
4378.3
4111.1
3292.2

balance-sheet.row.minority-interest

09.200
0
0
0
0
0
360.1

balance-sheet.row.total-equity

05352.25265.74272.8
3666.5
4351.2
4432.9
4078.1
3835.7
3123.8

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-

Total Investments

0221209.2211
239.9
206.6
200
1067
16.1
16.1

balance-sheet.row.total-debt

0233.120784.9
124.4
25
0
72.5
62.1
0

balance-sheet.row.net-debt

055.470.7-47.1
37.4
-24.1
-98.2
-26.3
-41.4
-50.8

Rahavoogude aruanne

Thyrocare Technologies Limited finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM20222021202020192018201720162015201420132012

cash-flows.row.net-income

0874.122791525.4
1464.8
1374
1449.9
816.7
818
676.2
461.6
568.2

cash-flows.row.depreciation-and-amortization

0387.1338.7302.8
319.1
261.7
201
180.5
182.4
128.7
63.6
33.1

cash-flows.row.deferred-income-tax

0-247.4-731.2-522.2
-474.4
-653.3
-640.7
-453.9
-348.5
-297.2
0
0

cash-flows.row.stock-based-compensation

0211.723.216.8
20
19.3
17.1
24.4
17.7
8.2
0
0

cash-flows.row.change-in-working-capital

057.9-792.2-176.5
337.8
-6.5
21.7
55.7
8.7
-168.6
-26.2
-0.5

cash-flows.row.account-receivables

0-14.3-587.2-288.1
-60.3
-27.9
-37.1
5.2
-24.7
0
-15.7
1

cash-flows.row.inventory

0-31.4-11.7-27.4
-25.4
-10.3
-25.6
-37.8
-33.5
-10.5
-10.5
-1.5

cash-flows.row.account-payables

074.2-84.831.5
143.5
9.1
-1.3
-5.4
12.1
0
0
0

cash-flows.row.other-working-capital

029.4-108.5107.5
280
22.6
85.8
93.8
54.7
-158.1
0
0

cash-flows.row.other-non-cash-items

09.716.61
11.5
7.9
21.3
-181.6
-348.8
-299.7
-36.6
-141.6

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-436.5-378.3-266.9
-99
-402.5
-436.5
-363.7
-144.2
-99.9
-147
-688

cash-flows.row.acquisitions-net

030.242.542.5
0.3
13.4
-100
0.6
0.8
-591.5
0
0

cash-flows.row.purchases-of-investments

0-1919.9-1730-1361.1
-1328.4
-1151.5
-914.3
-1227.7
-1064.9
-1317.4
0
0

cash-flows.row.sales-maturities-of-investments

01932.51593.51042.1
1429
1406.8
979.2
1125.7
999.2
1773.5
0
0

cash-flows.row.other-investing-activites

03.8236.656.8
7.6
17.9
39.4
49.9
32.5
55.7
-372.1
-194.7

cash-flows.row.net-cash-used-for-investing-activites

0-389.9-235.7-486.6
9.5
-115.9
-432.2
-415.1
-176.8
-179.7
-519.1
-882.7

cash-flows.row.debt-repayment

0-55.3-53.8-25
-43.9
-17.1
0
-10
0
0
0
0

cash-flows.row.common-stock-issued

00.30.30.3
0.4
0.4
0
0
0
0.3
0
0

cash-flows.row.common-stock-repurchased

0-55.3-53.8-62.6
-14.3
-630
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-793.5-793.1-528.4
-1319.6
-268.6
-537.2
-402.9
-379
-189.9
0
0

cash-flows.row.other-financing-activites

0426.3-0.1
-270.4
-21
-101.5
-72.3
-70.5
-38.9
0
8.1

cash-flows.row.net-cash-used-provided-by-financing-activities

0-861.8-894.1-615.8
-1647.8
-936.3
-638.7
-485.2
-449.6
-228.4
0
8.1

cash-flows.row.effect-of-forex-changes-on-cash

000-2.5
0
0
0
1
0
0
0
586.3

cash-flows.row.net-change-in-cash

041.44.344.9
40.5
-49.1
-0.6
-4.6
51.7
-63.5
-56.7
170.9

cash-flows.row.cash-at-end-of-period

0177.7136.3132
89.6
49.1
98.2
98.8
102.5
50.8
114.2
170.9

cash-flows.row.cash-at-beginning-of-period

0136.313287.1
49.1
98.2
98.8
103.5
50.8
114.2
170.9
0

cash-flows.row.operating-cash-flow

01293.11134.11147.3
1678.8
1003.1
1070.3
895.7
678
344.6
462.4
459.2

cash-flows.row.capital-expenditure

0-436.5-378.3-266.9
-99
-402.5
-436.5
-363.7
-144.2
-99.9
-147
-688

cash-flows.row.free-cash-flow

0856.6755.8880.4
1579.8
600.6
633.8
532
533.8
244.7
315.4
-228.8

Kasumiaruande rida

Thyrocare Technologies Limited tulud muutusid võrreldes eelmise perioodiga NaN%. THYROCARE.BO brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014

income-statement-row.row.total-revenue

05266.75888.64946.2
4342.6
4029.1
3563.2
3043.9
2409.7
1829.6

income-statement-row.row.cost-of-revenue

01632.31696.91639
1170.9
1105.3
949.8
814.2
703.6
583.1

income-statement-row.row.gross-profit

03634.44191.73307.2
3171.7
2923.8
2613.4
2229.6
1706.1
1246.5

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-

income-statement-row.row.other-expenses

04.41821.2
11.5
41
70.1
37
20.9
0

income-statement-row.row.operating-expenses

02788.22173.11895.9
1755.2
1642.9
1353.4
1237.4
948
631.3

income-statement-row.row.cost-and-expenses

04420.538703534.9
2926.1
2748.2
2303.2
2051.7
1651.5
1214.4

income-statement-row.row.interest-income

013.87.17.9
7
6.6
5
2
0.3
3.4

income-statement-row.row.interest-expense

023.523.78.7
18.5
6.1
4.4
2.7
5.5
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-0.4227.961.8
-65.5
83.7
167.8
-184.3
124.7
60.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

04.41821.2
11.5
41
70.1
37
20.9
0

income-statement-row.row.total-operating-expenses

0-0.4227.961.8
-65.5
83.7
167.8
-184.3
124.7
60.8

income-statement-row.row.interest-expense

023.523.78.7
18.5
6.1
4.4
2.7
5.5
0

income-statement-row.row.depreciation-and-amortization

0387.1338.7302.8
319.1
261.7
201
180.5
182.4
128.7

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-

income-statement-row.row.operating-income

0865.52044.21455.9
1457.5
1290.9
1279.9
999
693
615.3

income-statement-row.row.income-before-tax

0885.92277.21524.7
1404.1
1380.6
1449.9
816.7
818
676.2

income-statement-row.row.income-tax-expense

0242.3515.8393.2
520.1
529.2
517.1
388.3
300
235.8

income-statement-row.row.net-income

0643.61761.41131.5
884
851.4
932.8
428.4
518
452.2
Sarnased aktsiad
Sind võib huvitada ka:
HTGM
HTG Molecular Diagnostics, Inc..
0.48 USD
NASDAQ
CO
Global Cord Blood Corporation.
2.9876 USD
NYSE
ANPCF
ANGLE plc.
0.16678 USD
PNK
DIUXF
Diaceutics PLC.
1.3672 USD
PNK
MYGN
Myriad Genetics, Inc..
21.6 USD
NASDAQ
CNTG
Centogene N.V..
0.71 USD
NASDAQ
DMTK
DermTech, Inc..
0.6906 USD
NASDAQ
HTGMQ
HTG Molecular Diagnostics, Inc..
0.0015 USD
PNK
SQIDF
SQI Diagnostics Inc..
0.0149 USD
PNK

Korduma kippuv küsimus

Mis on Thyrocare Technologies Limited (THYROCARE.BO) koguvara?

Thyrocare Technologies Limited (THYROCARE.BO) koguvara on 6327200000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.708.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 16.845.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on 0.118.

Mis on ettevõtte kogutulu?

Kogutulu on 0.151.

Mis on Thyrocare Technologies Limited (THYROCARE.BO) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on 643600000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 233100000.000.

Mis on tegevuskulude arv?

Tegevuskulud on 2788200000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.